In any case, other studies in this topic indicate that even in this decade, experiencing MI will significantly increase the patient’s morbidity and mortality and place them at a severe disadvantage because CF patients with MI tend to have a higher likelihood of severe CFTR mutations [13]. This evidence concerns the gene CFTR and cystic fibrosis.